What is Health Canada doing with data provided in the Second Annual CIPARS Report?
AMR surveillance is a key element of Health Canada’s strategy to build a solid evidence base for developing overarching policies on antimicrobial use. Health Canada’s approach to addressing the reported prevalence of resistance includes supporting the expansion of ongoing retail surveillance, strengthening our efforts to encourage prudent use of antimicrobial drugs in food-producing animals, while continuing our support for AMR research, and monitoring AMR trends. The data collected must be interpreted in the context of a broader initiative to develop measures to control the spread of AMR in Canada. There are still evidence gaps and we will continue to monitor the emergence and persistence of AMR in food-borne pathogens isolated from food-producing animals in all Canadian provinces in order to have a nationally representative surveillance system.
